Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.

Different subtypes of depression are association with specific cardiometabolic diseases, according to new data out of the Netherlands. 

Adults with a history of CVD, type 2 diabetes and stroke were all associated with a lower dementia risk if they ate a whole food, plant-based diet. The study, published in JACC: Advances, was based on data from more than 71,000 U.K. Biobank participants. 

The new platform provides users with real-time access to high-quality electrocardiograms and patient data. The goal is to ensure everyone is on the same page at all times, with no unnecessary delays.

Cardiovascular disease remains the world’s leading cause of death, according to a special report from the American College of Cardiology. The new analysis, described by one cardiologist as a "wake-up call," includes data from more than 200 countries and territories.

Pediatric cardiologists can make a significant impact on global health trends by looking for early warning signs of CVD in their patients and collaborating with other physicians.

Researchers tracked real-world data from nearly 60,000 Medicare patients, highlighting the benefits of weekly injections of semaglutide. 

An updated version of Heartflow's Plaque Analysis platform has gained FDA clearance. In addition, the company announced that Cigna will cover the platform going forward.